
SALRESP I Salbutamol Sulfate Ipratropium Bromide 205mg/500mcg per 2.5ml x 35 Nebules
Generic Name: Salbutamol Sulfate + Ipratropium Bromide
Brand Name: Salresp I
Strength: 2.5mg/500mcg per 2.5ml
Quantity: 35 nebules
Type: Prescription Medicine – Nebulizer Solution
Philippines FDA Registration Number: DRP-1858
Product Description:
Salresp I contains Salbutamol Sulfate and Ipratropium Bromide nebulizer solution indicated for the management of bronchospasm associated with asthma and chronic obstructive pulmonary disease (COPD). Salbutamol is a short-acting beta-2 agonist that relaxes bronchial smooth muscle, while ipratropium is an anticholinergic that reduces airway constriction. For inhalation via nebulizer as prescribed by a physician.
Original: $12.95
-70%$12.95
$3.88SALRESP I Salbutamol Sulfate Ipratropium Bromide 205mg/500mcg per 2.5ml x 35 Nebules
Generic Name: Salbutamol Sulfate + Ipratropium Bromide
Brand Name: Salresp I
Strength: 2.5mg/500mcg per 2.5ml
Quantity: 35 nebules
Type: Prescription Medicine – Nebulizer Solution
Philippines FDA Registration Number: DRP-1858
Product Description:
Salresp I contains Salbutamol Sulfate and Ipratropium Bromide nebulizer solution indicated for the management of bronchospasm associated with asthma and chronic obstructive pulmonary disease (COPD). Salbutamol is a short-acting beta-2 agonist that relaxes bronchial smooth muscle, while ipratropium is an anticholinergic that reduces airway constriction. For inhalation via nebulizer as prescribed by a physician.
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
Generic Name: Salbutamol Sulfate + Ipratropium Bromide
Brand Name: Salresp I
Strength: 2.5mg/500mcg per 2.5ml
Quantity: 35 nebules
Type: Prescription Medicine – Nebulizer Solution
Philippines FDA Registration Number: DRP-1858
Product Description:
Salresp I contains Salbutamol Sulfate and Ipratropium Bromide nebulizer solution indicated for the management of bronchospasm associated with asthma and chronic obstructive pulmonary disease (COPD). Salbutamol is a short-acting beta-2 agonist that relaxes bronchial smooth muscle, while ipratropium is an anticholinergic that reduces airway constriction. For inhalation via nebulizer as prescribed by a physician.











